Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection.
Hall EM, Yin DE, Goyal RK, Ahmed AA, Mitchell GS, St Peter SD, Flatt TG, Ahmed IA, Li W, Hendrickson RJ, August KJ, Myers GD.
Hall EM, et al. Among authors: mitchell gs.
J Immunother Cancer. 2021 Jan;9(1):e001225. doi: 10.1136/jitc-2020-001225.
J Immunother Cancer. 2021.
PMID: 33472856
Free PMC article.